Home
About the PCRJ
Aims, Scope and History
Editorial Board
Online first
Current Issue
education@pcrj
Past Issues
Supplements
Translations
Most popular articles
Alerts
Subscribe
Instructions for Authors
Advertising
Disclaimer and Legal Notices
Contact Us
PDF View full text as PDF document

PowerPoint Download a slideset for this article (PowerPoint document)

CrossRef Right click on this DOI link and copy link/shortcut to cite this article (What is a DOI link?)

Export Export to bibliographic software or plain text

CiteULike Post to CiteULike

Email this article Email this article to friend/s or colleague/s

Cited by Cited by
•   Back to table of contents

Volume 17 Issue 3 September 2008

Review

Management of acute rhinosinusitis in primary care: changing paradigms and the emerging role of intranasal corticosteroids

Pages 148-155
*Dermot Ryana,b

a Woodbrook Medical Centre, Loughborough, Leicestershire, UK

b Research Fellow, Department of General Practice, University of Aberdeen, Scotland, UK

Online 12 August 2008


Abstract
Primary care physicians are frequently confronted with patients suffering from symptoms of acute rhinosinusitis (RS), and may resort to antibiotic management guided by traditional treatment approaches or in response to patient expectations. Acute RS symptoms are now thought to be caused largely by host inflammatory responses and not solely by infectious agents as was once assumed. An increasing amount of evidence confirms that, for routine treatment of uncomplicated acute RS, antibiotics are of little or no benefit in most cases. Further, inappropriate prescription of antibiotics for acute RS contributes to the worsening problem of antibiotic resistance, puts patients at risk of unnecessary side effects, and drives up the cost of medical care. Therefore, treatment goals are shifting toward efforts to quell the inflammatory process in the sinuses and restore normal sinus functioning. Clinical studies with intranasal corticosteroids support their usefulness as monotherapy or adjunctive therapy in relieving symptoms of acute RS, and recently published treatment guidelines recommend their use as a general management measure for RS, with antibiotics reserved only for more severe cases when a bacterial aetiology is highly suspected. This changing paradigm reflects current understanding of acute RS pathophysiology, and addresses the need to curtail unnecessary antibiotic usage.

Cite as: Ryan D. Management of acute rhinosinusitis in primary care: changing paradigms and the emerging role of intranasal corticosteroids. Prim Care Respir J 2008;17(3):148-155. DOI: http://dx.doi.org/10.3132/pcrj.2008.00050

Keywords
Antibiotics, corticosteroids, intranasal, primary care, acute rhinosinusitis

* Corresponding author. Dermot Ryan Tel: +44 (0)1224 553972 Fax: +44 (0)1224 550683 Email: dermotryan@doctors.org.uk